N2Jenomics Lab Pvt. Ltd. provides reliable and cost-effective Mitochondrial DNA (mtDNA) Sequencing services using both Illumina and PacBio sequencing platforms. Our solutions deliver high-quality data for disease research, population genetics, evolutionary studies, and biodiversity analysis.
Mitochondrial DNA (mtDNA) sequencing analyzes the complete mitochondrial genome to identify genetic variants associated with inherited disorders, aging, cancer, neurological diseases, and metabolic conditions. It is also widely used in evolutionary biology, population genetics, and species identification.
Using advanced sequencing technologies, researchers can accurately detect heteroplasmy, characterize mitochondrial variants, and gain valuable insights into mitochondrial function and disease mechanisms.
We offer flexible sequencing solutions tailored to different research needs:
![]() | Sample requirements
|
![]() | Sequencing
|
![]() | Data Analysis
|

Mitochondrial DNA has a high mutation rate, exists in multiple copies per cell, and does not undergo recombination. These characteristics make it highly suitable for studying inherited disorders, evolutionary relationships, population genetics, and species identification.
Yes. Whole Genome Sequencing (WGS) generally includes both nuclear DNA and mitochondrial DNA. Depending on the sequencing platform and analysis workflow, mtDNA variants can be identified alongside genomic variants for comprehensive genetic analysis.
Common challenges include detecting low-frequency heteroplasmic variants, distinguishing genuine mtDNA from nuclear mitochondrial DNA segments (NUMTs), ensuring sufficient sequencing depth, and accurately analyzing highly variable mitochondrial genomes.
Human mtDNA sequencing can be performed using genomic DNA extracted from blood, saliva, tissue, or other biological samples. Since mitochondrial DNA is naturally present within cells, separate isolation of mtDNA is generally not required for targeted capture or sequencing workflows.


